GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » Net Income From Continuing Operations

Cian Healthcare (BOM:542678) Net Income From Continuing Operations : ₹0.8 Mil (TTM As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Cian Healthcare Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Cian Healthcare's net income from continuing operations for the six months ended in Sep. 2023 was ₹-14.8 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.8 Mil.


Cian Healthcare Net Income From Continuing Operations Historical Data

The historical data trend for Cian Healthcare's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cian Healthcare Net Income From Continuing Operations Chart

Cian Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Income From Continuing Operations
Get a 7-Day Free Trial 6.55 -37.88 0.53 -55.34 20.30

Cian Healthcare Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.34 -38.52 4.77 15.52 -14.77

Cian Healthcare Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cian Healthcare (BOM:542678) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Vitthal Rao Shivarkar Road, Office No. 508-511, 5th Floor, Sacred World, Above Macdonald, Wanowrie, Pune, MH, IND, 411040
Cian Healthcare Ltd is a fully integrated pharmaceutical company. It is engaged in the research, development, and manufacturing of different forms of tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets. The company's portfolio comprises of gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotics, CNS, vitamins, and nutrient products. It operates in five sectors namely Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party. The majority of the revenue is generated from the Indian Market.

Cian Healthcare (BOM:542678) Headlines

No Headlines